Free Trial

Stratec (ETR:SBS) Shares Down 0.9% - Should You Sell?

Stratec logo with Medical background

Stratec SE (ETR:SBS - Get Free Report) shares dropped 0.9% on Thursday . The stock traded as low as €27.20 ($28.63) and last traded at €27.70 ($29.16). Approximately 7,207 shares changed hands during mid-day trading, an increase of 15% from the average daily volume of 6,253 shares. The stock had previously closed at €27.95 ($29.42).

Stratec Trading Down 0.9 %

The company has a fifty day moving average of €38.40 and a two-hundred day moving average of €41.89. The company has a current ratio of 2.47, a quick ratio of 1.65 and a debt-to-equity ratio of 65.99. The stock has a market capitalization of $336.83 million, a price-to-earnings ratio of 23.28, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16.

Stratec Company Profile

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

See Also

Should you invest $1,000 in Stratec right now?

Before you consider Stratec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stratec wasn't on the list.

While Stratec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines